L Catterton completes acquisition of Thorne HealthTech

L Catterton announced the completion of its acquisition of Thorne HealthTech. The tender offer to purchase all of the issued and outstanding shares of Thorne’s common stock in exchange for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes, expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended. L Catterton previously announced that, as of the Expiration Time, 52,596,517 Shares were validly tendered and not validly withdrawn in the Offer, representing 97.3% of the issued and outstanding Shares as of the Expiration Time. In accordance with the terms of the Offer, L Catterton and its affiliate, Healthspan Merger Sub, Inc., accepted for payment all such Shares that were validly tendered and not validly withdrawn pursuant to the Offer. Following completion of the Offer, L Catterton completed the acquisition of Thorne through the previously planned second-step merger. Thorne’s common stock will be delisted from the Nasdaq Global Select Market and deregistered under the Securities Exchange Act of 1934, as amended.